Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland.

C Simone SutherlandZanfina AdemiJoëlle MichaudNadine SchurMyriam LinggArjun BhadhuriThierry D PacheJohannes BitzerPierre SuchonValerie Albert Hersberger KurtGoranka TanackovicMatthias Schwenkglenks

Published in: BMJ open (2019)

The PP test may be cost effective in Switzerland for screening women seeking CHCs for their risk of VTE based on the current evidence.

Keyphrases

venous thromboembolism
polycystic ovary syndrome
direct oral anticoagulants
pregnancy outcomes
healthcare
palliative care
insulin resistance
cervical cancer screening
mental health
breast cancer risk
quality improvement
type diabetes
copy number
pregnant women